Read Chrissy Like Chrissy on Facebook Follow Chrissy on Twitter Follow Chrissy's Pins Contact Chrissy
Showing posts with label pf. Show all posts
Showing posts with label pf. Show all posts

Saturday, September 11, 2010

National Pulmonary Fibrosis Awareness Week

Do me a favor. Take the deepest breath you can take; let half of it out. Take another breath, as deep as you can; let half of THAT out. Keep going until it hurts too much to continue. Imagine that feeling, coupled with a dry, papery cough and that nagging sensation that you can't quite clear your throat. Now try to think, move, or concentrate.

That's what Pulmonary Fibrosis feels like. It doesn't get better and it never goes away. The lungs you see pictured here are an example of one PF lung, and one that is still healthy.

This week is National Pulmonary Fibrosis Awareness Week. Below is the text of the National Coalition for Pulmonary Fibrosis' email kicking if off. I hope the information is helpful.

Coalition for Pulmonary Fibrosis

8th ANNUAL NATIONAL PULMONARY FIBROSIS AWARENESS WEEK SEPT. 11-18

Culver City, Calif. - The Coalition for Pulmonary Fibrosis (CPF) kicks off the 8th annual National Pulmonary Fibrosis (PF) Awareness Week Sept. 11 to 18. The primary goals of this year's activity are to ensure passage of the Pulmonary Fibrosis Research Enhancement Act (PFREA), in the Senate and the House, and to raise awareness of Pulmonary Fibrosis issues in communities nationwide.

Specifically, the CPF is asking its national membership and others affected by PF to email, call, or mail letters to their members of Congress to encourage their votes for PFREA. The CPF's objectives while on the Hill are to add co-sponsors to the 136 on the House bill as of this date, and to begin to build a list of Senate co-sponsors.

National PF Awareness Week will mean more than 50 visits by patients and patient advocates with legislators on Capitol Hill. Hundreds of other patients and family members will reach out to their own members of Congress in their home districts nationwide that week.

The CPF has worked closely with Congressmen Brian Baird (D-WA) and Mike Castle (R-DE) on the House version (H.R. 1079) and with Senators Patty Murray and Mike Crapo on the Senate version (S. 3073). This historic, bi-partisan legislation would authorize $16 million in new federal funding to create the first national patient registry for PF, and provide much needed support for research into the deadly lung disease.

"It takes each PF patient, each family member and their circle of friends to reach out to Congress and get this bill passed," said Mishka Michon, Chief Executive Officer of the CPF. "Having the voice of the patient community heard loud and clear will make things happen to bring attention and awareness to PF in Washington and beyond."

This year, 2010, has been proclaimed international "Year of the Lung" by the American Thoracic Society (ATS) and respiratory societies around the globe. The CPF is partnering with this alliance in a concerted effort to bring attention to lung issues. National PF Week will continue that effort.

The progression from a bill of recognition of the disease, H. Con Res 182, which was passed in 2007 to a bill establishing funding for PF research, is indicative of increased responsiveness on the part of Congress. Over the past eight years, the CPF and its advocates have met with hundreds of Members of Congress.

PF patients, families and those affected by PF can help with 2010 awareness efforts and help gain passage of the PFREA by joining the CPF's advocacy campaign, Campaign ACT. For further information, visit the CPF at www.coalitionforpf.org, call 888-222-8541, or email info@coalitionforpf.org.

Disparity of Federal Funding

The disparity of federal funds for research in pulmonary fibrosis is profound. This year, less than $23 million will be spent on this disease which affects 128,000 people compared with hundreds of millions of dollars spent on diseases that affect a small fraction of that number. This, while the disease takes 40,000 lives each year - the same number as breast cancer. H.R. 1079 will provide much needed help for PF patients by creating the first national patient registry and providing support for research.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. There is currently no known cause or cure. Approximately one percent of patients' lives are extended through lung transplants. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF's Campaign ACT

Since 2002, the CPF has been leading a national advocacy effort directed toward Congress, the National Institutes of Health and the Centers for Disease Control to increase research funding for PF and accelerate efforts to find a cure for this devastating lung disorder. The CPF has also actively advocated for passage of legislation important to the PF community in the areas of Medicare and Social Security coverage.

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's monprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 23,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.

Tuesday, July 20, 2010

PF Awareness Week

I'm sharing this email from the Coalition for Pulmonary Fibrosis. Read on!

National Pulmonary Fibrosis Awareness Week 2010 has been set for September 11-18.

The CPF encourages you to set up a meeting with your Member of Congress soon for a meeting during the August recess (August 9-September 12) to personally ask for their support of the Pulmonary Fibrosis Research Enhancement Act (HR 1079).

We need your help now to insure the bill gets passed this Congress (since it's a Congressional election year, this means we don't have much time!). If you can't meet in erson -- there are other ways you can make a difference! See below for details!

REMEMBER, THERE ARE THREE EASY WAYS TO HELP!

1. VISIT YOUR REPRESENTATIVE IN DISTRICT

2. CALL YOUR REPRESENTATIVE OVER THE SUMMER BREAK

3. SEND A LETTER or EMAIL

1) CPF Advocacy Efforts This Summer - Get Involved Locally (VISIT YOUR MEMBER IN DISTRICT)

The CPF encourages you to schedule a meeting now with your member of Congress during the August recess when he/she is in your home district to support the Pulmonary Fibrosis Research Enhancement Act. Letters are important, but having a face-to-face meeting with your Member of the U.S. House of Representatives will allow you to share your personal story of your connection to PF and personally ask for your Member of Congress' support of H.R. 1079, the first legislation that will directly help PF patients! If your member is already a co-sponsor, visit him/her and thank them for their support. There are currently 133 co-sponsors on the bill. A full listing of members currently signed on is pasted further down
in this email.

2) Take action today by calling your Representative! Please contact your House Representative NOW to request their cosponsorship of H.R. 1079 and ask them to support a Congressional hearing on PF!

How to Contact your Representative:

Call the Capitol Switchboard at 1-202-224-3121 and ask for your Representative or give your zipcode if you don't know their name. When you are connected to an office, ask for the Health Legislative Assistant. If you leave a voicemail message, include your name and phone number so they can call you back. Also, it may be helpful to include your city, as well.

Sample phone message:

"I am a constituent and a Pulmonary Fibrosis (patient, family, friend) and I am calling to ask Rep./Sen. ____ to cosponsor the Pulmonary Fibrosis Research Enhancement Act. This bill will create a much needed national patient registry so that scientists and researchers can learn more about the disease as quickly as possible so that treatments may be found. There is currently no FDA approved treatment for PF and as many people die to it each year as breast cancer. Please help us now by signing onto H.R. 1079 and supporting a hearing on PF to Rep. Pallone."

3) Send an email or letter to your Representative:

CLICK HERE

The CPF also encourages you to plan activities in your hometown to raise awareness amongst your friends, family, co-workers, colleagues and neighbors about PF. Come up with a creative way to celebrate PF Week and spread the word about PF!

Thank you for your ongoing support of the Coalition for Pulmonary Fibrosis! Please ask your friends, family, and co-workers to support PF Week, too!

Sincerely,
YOUR NAME

****************************************

CPF Chief Executive Officer

CPF ANNOUNCES DATES FOR EIGHTH ANNUAL NATIONAL PULMONARY FIBROSIS AWARENESS WEEK 2010 Awareness Efforts Set for PF Week Sept. 11-18

The Coalition for Pulmonary Fibrosis (CPF) announced today it has set its 2010 National Pulmonary Fibrosis (PF) Awareness Week for September 11-18, 2010. The primary goals of this year's activity are to ensure passage of the Pulmonary Fibrosis Research Enhancement Act (PFREA), and to raise awareness of PF issues to Members of Congress and in communities nationwide.

Specifically, the CPF is asking its national membership and others affected by PF to take action on the Pulmonary Fibrosis Research Enhancement Act (PFREA), H.R. 1079, by meeting with their Members in person or by emailing, calling or mailing letters to them.

The CPF will celebrate National PF Awareness Week with more than 20 patients and patient advocates on Capitol Hill, and with hundreds of patients and family members reaching out to their own Members in their districts nationwide that week. In 2009, the organization received recognition for its National PF Awareness Week's efforts when it was a finalist for a national advocacy award by PR Week.

The CPF has been working closely with Congressman Brian Baird (D-WA) and Congressman Mike Castle (R-DE) on PFREA, the lead sponsors of the bill. This historic, bi-partisan legislation would authorize $16 million in new federal funding to create the first national patient registry for PF, and provide much needed support for research into the deadly lung disease.

"It takes each PF patient, each family member and their circle of friends to reach out to Congress and get this bill passed," said Mishka Michon, Chief Executive Officer of the CPF. "Having the voice of the patient community heard loud and clear will make things happen to bring attention and awareness to PF in Washington and beyond."

As part of the National PF Week efforts, there will be a walk in Washington, DC, not far from the Capitol steps, to bring attention and awareness to pulmonary fibrosis and the millions of lives it touches globally. This year, 2010, has been proclaimed international "Year of the Lung" by the American Thoracic Society (ATS) and a coalition of like respiratory societies around the globe. The CPF is partnering with this coalition in a concerted effort to bring attention to lung issues. National PF Week will continue that effort.

This focused effort on the part of the CPF is moving into its eighth year. The progression from a bill of recognition of the disease, H. Con Res 182, which was passed in 2007 to a bill establishing funding for PF research, is indicative of increased responsiveness on the part of Congress. Over the years, the CPF and its advocates have met with hundreds of Members of Congress. 127 House Members are now supporters of the current bill.

PF patients, families and those affected by PF can help with 2010 Awareness efforts and help gain passage of the PFREA by joining the CPF's advocacy campaign, Campaign ACT. For further information, please visit the CPF at www.coalitionforpf.org, call us at 888-222-8541, or email us at info@coalitionforpf.org.

Current Co-Sponsors of HR 1079 along with the dates they signed on:

Rep Baca, Joe [CA-43] - 12/1/2009
Rep Barrow, John [GA-12] - 11/5/2009

Rep Bishop, Rob [UT-1] - 10/1/2009
Rep Bishop, Sanford D., Jr. [GA-2] - 2/4/2010

Rep Blackburn, Marsha [TN-7] - 7/31/2009
Rep Blumenauer, Earl [OR-3] - 2/4/2010

Rep Blunt, Roy [MO-7] - 2/22/2010
Rep Boccieri, John A. [OH-16] - 5/6/2009

Rep Bono Mack, Mary [CA-45] - 2/4/2010
Rep Boozman, John [AR-3] - 9/10/2009

Rep Boren, Dan [OK-2] - 3/11/2009
Rep Boucher, Rick [VA-9] - 12/1/2009

Rep Brady, Kevin [TX-8] - 2/4/2010
Rep Braley, Bruce L. [IA-1] - 10/22/2009

Rep Burgess, Michael C. [TX-26] - 6/12/2009
Rep Butterfield, G. K. [NC-1] - 2/4/2010

Rep Capps, Lois [CA-23] - 3/9/2010
Rep Cardoza, Dennis A. [CA-18] - 7/21/2009

Rep Carney, Christopher P. [PA-10] - 3/4/2010
Rep Carson, Andre [IN-7] - 3/4/2010

Rep Castle, Michael N. [DE] - 2/13/2009
Rep Christensen, Donna M. [VI] - 2/4/2010

Rep Cohen, Steve [TN-9] - 1/20/2010
Rep Connolly, Gerald E. "Gerry" [VA-11] - 12/16/2009

Rep Conyers, John, Jr. [MI-14] - 2/4/2010
Rep Courtney, Joe [CT-2] - 1/27/2010

Rep Cummings, Elijah E. [MD-7] - 12/14/2009
Rep Deal, Nathan [GA-9] - 2/13/2009

Rep DeFazio, Peter A. [OR-4] - 7/21/2009
Rep DeGette, Diana [CO-1] - 9/25/2009

Rep Diaz-Balart, Lincoln [FL-21] - 9/17/2009
Rep Dicks, Norman D. [WA-6] - 2/13/2009

Rep Doyle, Michael F. [PA-14] - 2/4/2010
Rep Edwards, Donna F. [MD-4] - 2/4/2010

Rep Ellison, Keith [MN-5] - 10/6/2009
Rep Ellsworth, Brad [IN-8] - 2/22/2010

Rep Emerson, Jo Ann [MO-8] - 2/4/2010
Rep Eshoo, Anna G. [CA-14] - 2/4/2010

Rep Filner, Bob [CA-51] - 6/29/2010
Rep Frank, Barney [MA-4] - 9/17/2009

Rep Franks, Trent [AZ-2] - 1/13/2010
Rep Gallegly, Elton [CA-24] - 9/10/2009

Rep Gerlach, Jim [PA-6] - 2/13/2009
Rep Gingrey, Phil [GA-11] - 12/3/2009

Rep Gonzalez, Charles A. [TX-20] - 2/4/2010
Rep Goodlatte, Bob [VA-6] - 3/11/2009

Rep Gordon, Bart [TN-6] - 3/26/2009
Rep Green, Gene [TX-29] - 9/17/2009

Rep Grijalva, Raul M. [AZ-7] - 12/16/2009
Rep Hall, John J. [NY-19] - 5/6/2009

Rep Hall, Ralph M. [TX-4] - 2/4/2010
Rep Harman, Jane [CA-36] - 2/13/2009

Rep Harper, Gregg [MS-3] - 5/6/2009
Rep Hill, Baron P. [IN-9] - 3/3/2010

Rep Hinchey, Maurice D. [NY-22] - 2/4/2010
Rep Hirono, Mazie K. [HI-2] - 2/4/2010

Rep Hodes, Paul W. [NH-2] - 2/4/2010
Rep Holt, Rush D. [NJ-12] - 12/14/2009

Rep Inslee, Jay [WA-1] - 2/4/2010
Rep Jones, Walter B., Jr. [NC-3] - 9/10/2009

Rep Kaptur, Marcy [OH-9] - 2/13/2009
Rep Kilroy, Mary Jo [OH-15] - 2/25/2010

Rep Kirk, Mark Steven [IL-10] - 2/13/2009
Rep Kosmas, Suzanne M. [FL-24] - 10/13/2009

Rep Kucinich, Dennis J. [OH-10] - 4/22/2010
Rep Langevin, James R. [RI-2] - 12/8/2009

Rep Larsen, Rick [WA-2] - 1/12/2010
Rep Latham, Tom [IA-4] - 3/26/2009

Rep LaTourette, Steven C. [OH-14] - 2/13/2009
Rep Lewis, John [GA-5] - 2/4/2010

Rep Linder, John [GA-7] - 2/4/2010
Rep Loebsack, David [IA-2] - 10/22/2009

Rep Lofgren, Zoe [CA-16] - 2/13/2009
Rep Mack, Connie [FL-14] - 2/4/2010

Rep Maffei, Daniel B. [NY-25] - 6/30/2010
Rep Markey, Betsy [CO-4] - 1/20/2010

Rep Markey, Edward J. [MA-7] - 4/21/2010
Rep Marshall, Jim [GA-8] - 4/27/2009

Rep Matheson, Jim [UT-2] - 2/4/2010
Rep Matsui, Doris O. [CA-5] - 2/4/2010

Rep McCotter, Thaddeus G. [MI-11] - 9/10/2009
Rep McGovern, James P. [MA-3] - 4/27/2009

Rep Melancon, Charlie [LA-3] - 2/4/2010
Rep Michaud, Michael H. [ME-2] - 6/17/2010

Rep Miller, Brad [NC-13] - 6/22/2010
Rep Minnick, Walter [ID-1] - 5/6/2009

Rep Moran, James P. [VA-8] - 3/11/2009
Rep Moran, Jerry [KS-1] - 4/27/2010

Rep Murphy, Christopher S. [CT-5] - 9/17/2009
Rep Murphy, Patrick J. [PA-8] - 2/4/2010

Rep Murphy, Tim [PA-18] - 2/4/2010
Rep Napolitano, Grace F. [CA-38] - 5/6/2009

Rep Olver, John W. [MA-1] - 6/16/2010
Rep Pascrell, Bill, Jr. [NJ-8] - 4/27/2009

Rep Paulsen, Erik [MN-3] - 9/17/2009
Rep Pingree, Chellie [ME-1] - 2/3/2010

Rep Pitts, Joseph R. [PA-16] - 9/22/2009
Rep Platts, Todd Russell [PA-19] - 6/12/2009

Rep Price, David E. [NC-4] - 5/20/2009
Rep Reyes, Silvestre [TX-16] - 2/4/2010

Rep Rogers, Mike D. [AL-3] - 9/17/2009
Rep Rothman, Steven R. [NJ-9] - 2/3/2010

Rep Roybal-Allard, Lucille [CA-34] - 9/17/2009
Rep Ryan, Tim [OH-17] - 1/13/2010

Rep Sarbanes, John P. [MD-3] - 3/26/2009
Rep Scalise, Steve [LA-1] - 10/6/2009

Rep Schakowsky, Janice D. [IL-9] - 9/22/2009
Rep Schiff, Adam B. [CA-29] - 10/6/2009

Rep Schock, Aaron [IL-18] - 5/28/2010
Rep Sestak, Joe [PA-7] - 6/12/2009

Rep Sherman, Brad [CA-27] - 7/30/2009
Rep Shimkus, John [IL-19] - 2/4/2010

Rep Simpson, Michael K. [ID-2] - 9/10/2009
Rep Smith, Adam [WA-9] - 2/4/2010

Rep Space, Zachary T. [OH-18] - 2/13/2009
Rep Stupak, Bart [MI-1] - 2/4/2010

Rep Sutton, Betty [OH-13] - 2/3/2010
Rep Taylor, Gene [MS-4] - 2/4/2010

Rep Thompson, Bennie G. [MS-2] - 2/4/2010
Rep Thompson, Glenn [PA-5] - 5/18/2010

Rep Tierney, John F. [MA-6] - 2/13/2009
Rep Tonko, Paul D. [NY-21] - 2/4/2010

Rep Towns, Edolphus [NY-10] - 10/6/2009
Rep Tsongas, Niki [MA-5] - 2/4/2010

Rep Upton, Fred [MI-6] - 2/4/2010
Rep Van Hollen, Chris [MD-8] - 9/10/2009

Rep Walden, Greg [OR-2] - 2/4/2010
Rep Walz, Timothy J. [MN-1] - 2/25/2010

Rep Weiner, Anthony D. [NY-9] - 2/4/2010
Rep Welch, Peter [VT] - 5/20/2009

Rep Wolf, Frank R. [VA-10] - 3/11/2009
Rep Woolsey, Lynn C. [CA-6] - 12/14/2009

Rep Young, C.W. Bill [FL-10] - 2/13/2009

Coalition for Pulmonary Fibrosis
Suite F, #227
1659 Branham Lane
San Jose, CA 95118-5226
(888) 222-8541
info@coalitionforpf.org

Tuesday, March 16, 2010

My Week In Jail

I will be vanishing off and on this spring as I try to outrun PF and the boogie men it hired to chase me. Last week I had my trachea re-aligned. I'll be getting some more of that fun torture this week, too. It sucks, hurts, and makes me bitchy.

So... pretty much... well, other than me not talking a lot and laying down a lot, it's pretty much business as usual.

One distressing development was the sudden death of my beloved netbook. I can't blame the poor thing for taking a facer... I have beat the hell out of it. Plus my nephew dumped almost a full bottle of rootbeer on it about a month after I got it. And I crammed 2GB into it and ran old versions of Paint Shop Pro and Dreamweaver. I'm pretty sure I can get a tech nerd to fix it, but don't really want to push my luck too much. So I will repair it later, use my normal-sized notebook in the mean time, and shop for something new to use every day.

Enter my new obsession... Naturally I don't want something I can pick up just anywhere. And I got Ahmed the full-sized version of this little darling a while back. He loves it because he has ginourmous hands and can't navigate touch pads or keys as easily as the rest of us.

One of my first laptops was a Fujitsu and I adore the company. Now, along comes the weenie tablet netbook... omg. LUST!!

It comes with a stylus, but you can use your fingers to resize images. You can even poke the screen in stead. And the very idea of being able to rotate the screen, lay it flat, and draw... or read and ebook... or browse without typing...

GAH!! MUST HAVE!!!

Anyway, I am allowed to be goofing off online for a while today since my upper body is not hurting bad enough to need pain killers. I dislike pain killers. I don't like being in agony, but addiction terrifies me and I think when you are chronically sick it's way too easy to fall into the habit of escape.

So my drug, for today, is nerd-lust for the Fujitsu Lifebook Tablet PC Micro. Feel free to join me in drooling.

Thursday, December 03, 2009

Help

Most people who are diagnosed with pulmonary fibrosis live less than five years beyond the diagnosis. There is no FDA approved cure. There is no FDA approved treatment. The current experimental treatments are for slowing progression or easing symptoms-- none are for a cure.

Please help by clicking this simple link and voting for CHASE to donate to our cause. It costs nothing.



Thanks.

Monday, September 01, 2008

Agence France Reports New PF Treatment Looms

Australian researchers Monday said they had developed a drug which could potentially spell an end to a life-threatening condition caused by diabetes, heart disease and fibrotic illnesses.

Scientists from the University of Melbourne and the city's St Vincent's Hospital said the drug had been shown in animal trials to prevent fibrosis, the build-up of irreversible scarring on internal organs.

There are currently no treatments on the market for fibrosis and the new drug, called FT-11, could be as important a discovery as blood pressure drugs if effective, said Professor Darren Kelly of the University of Melbourne.

"It would be an enormous blockbuster drug with an initial market of around 2.0 billion dollars," he said.

Kelly said while the drug would not prevent diabetes -- a chronic illness in which the body fails to produce enough of the hormone insulin to process sugar -- it could prevent complications such as kidney or heart disease.

"We are hoping to delay or prevent those complications which would basically keep those patients off dialysis -- which would have a huge benefit for their lifestyle," Kelly told AFP.

The drug, expected to be tested in clinical trials within 12 months, could be used to prevent diabetic kidney disease, heart disease and potentially other health problems such as liver and lung fibrosis, he said.

Speaking to the Australian Broadcasting Corporation, Kelly said about 45 percent of diseases in the developed world could be associated with some sort of pathological fibrosis.

"We know at the moment in rat studies that our compound inhibited the development of fibrosis, and the interesting thing in the future would be to see whether we can actually reverse fibrosis," he said.

-- Monday, August 18th; Agence France Presse.